loading

Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 7.00 - -
Operating Expenses
31.45%
23.71
34.59 32.53 26.78 24.52
Interest Income/Expense
0.25%
0.40
0.399 0.396 0.385 0.37
Operating Income/Loss
31.45%
-23.71
-34.59 -25.53 -26.78 -24.52
Income/Loss From Continuing Operations Before Tax
32.86%
-21.66
-32.26 7.00 -24.31 -22.20
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
32.86%
-21.66
-32.26 -23.10 -24.31 -22.20
Net Income/Loss
32.86%
-21.66
-32.26 -23.10 -24.31 -22.20
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
117.75K%
72.80
0.0618 72.68 72.46 72.33
Diluted Average Shares
117.75K%
72.80
0.0618 72.68 72.46 72.33
Basic Earnings Per Share
31.82%
-0.30
-0.44 -0.32 -0.34 -0.31
Diluted Earnings Per Share
31.82%
-0.30
-0.44 -0.32 -0.34 -0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.81
price up icon 4.44%
$68.57
price up icon 5.80%
$31.95
price up icon 2.37%
$23.24
price up icon 15.33%
biotechnology ONC
$230.36
price up icon 10.59%
$96.52
price up icon 3.65%
Kapitalisierung:     |  Volumen (24h):